Thirty Madison, a New York-based healthcare company that focuses on people with chronic conditions, raised $140M in Series C funding.
The round was led by new investor HealthQuest Capital with participation from Mousse Partners and Bracket Capital and existing investors Polaris Partners, Johnson & Johnson Innovation – JJDC, Inc., Northzone, Greycroft, and others. In conjunction with the funding, Randy Scott, Partner at HealthQuest Capital, will join Jason Stoffer, Partner at Maveron, and Amy Schulman, Managing Partner at Polaris Partners, as a member of Thirty Madison’s Board of Directors.
The company, which has raised a total of $210m to date and is now valued at over $1 billion, intends to use the funds to expand access to its care model for people who suffer from chronic conditions and enhance the capabilities of its proprietary platform.
Led by Steven Gutentag, co-founder and CEO, Thirty Madison is the premier healthcare company for people living with chronic conditions. Its specialized care model, powered by a proprietary platform, provides care to an increasing number of patients via:
- Keeps for men’s hair loss,
- Evens for gastrointestinal conditions,
- Cove for migraine, and
- Picnic for allergies.